Blog
RSS FeedPosted by Michael Wonder on 20 Nov 2019
Life saving therapy denied to dying cop
20 November 2019 - Doctors at Sydney’s Royal Prince Alfred Hospital are refusing to treat a terminally ill cancer patient ...
Posted by Michael Wonder on 19 Nov 2019
Game changing cancer medicines now within reach for 2,200 Australians
20 November 2019 - Australians living with non-small cell lung cancer and early stage acute lymphoblastic leukaemia will be able to ...
Posted by Michael Wonder on 19 Nov 2019
Lung cancer and leukaemia treatments to be added to PBS
19 November 2019 - “Game changing” drugs for types of lung cancer and leukaemia will be added to the Pharmaceutical Benefits ...
Posted by Michael Wonder on 18 Nov 2019
Ontario and Quebec provide reimbursement for HIV therapies Pifeltro (doravirine) and Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate)
18 November 2019 - For more than 30 years, Merck has been committed to scientific research and discovery in HIV that ...
Posted by Michael Wonder on 18 Nov 2019
Nancy Brunning's death: calls for PHARMAC reform
18 November 2019 - There are calls for PHARMAC to be reformed after the death of actress Nancy Brunning. ...
Posted by Michael Wonder on 18 Nov 2019
'This drug saved my life;' cystic fibrosis patient accuses drug company, Canada of stalling on approval
17 November 2019 - A West Island woman living with cystic fibrosis says the prohibitive price of a drug is ...
Posted by Michael Wonder on 15 Nov 2019
PHARMAC backs down on epilepsy drug brand switch
15 November 2019 - PHARMAC has backed down on a controversial drug brand switch affecting patients with epilepsy and mental ...
Posted by Michael Wonder on 15 Nov 2019
Meningitis Foundation calls for PHARMAC to protect everyone
15 November 2019 - Following PHARMAC’s announcement stating the meningococcal ACWY vaccine will be available free from next month for ...
Posted by Michael Wonder on 15 Nov 2019
PHARMAC to widen access to the exceptional circumstances process for lamotrigine
15 November 2019 - Patients taking lamotrigine who have concerns about the change can talk with their doctor about remaining ...
Posted by Michael Wonder on 14 Nov 2019
NICE ‘OK’ for Sativex in MS
14 November 2019 - NICE has recommended Bayer’s Sativex (delta-9 tetrahydrocannabinol cannabidiol), for spasticity in people with multiple sclerosis. ...
Posted by Michael Wonder on 14 Nov 2019
PHARMAC widening access to the meningococcal ACWY vaccine
14 November 2019 - The meningococcal ACWY vaccine will be available free from next month for young people in close ...
Posted by Michael Wonder on 13 Nov 2019
Regulators’ advice can make a difference for faster patient access to highly innovative therapies
12 November 2019 - Early dialogue and frequent interactions between medicine developers, regulators, health technology assessment bodies and patients can play ...
Posted by Michael Wonder on 13 Nov 2019
Clovis Oncology announces reimbursement for Rubraca (rucaparib) tablets for women with relapsed ovarian cancer in Italy
13 November 2019 - Rucaparib now reimbursed in several countries in Europe with additional countries to follow in 2020. ...
Posted by Michael Wonder on 11 Nov 2019
Medical cannabis ruled out for chronic pain by NHS drug watchdog in decision branded 'devastating'
11 November 2019 - Cannabis should not be prescribed for chronic pain, the NHS funding watchdog has ruled, in a ...
Posted by Michael Wonder on 11 Nov 2019
China’s drug market is opening up
11 November 2019 - Beijing’s health-care reforms are giving global pharmaceutical companies better access to the world’s second-largest drug market. ...